OS Benefit With Abemaciclib for HR-positive/HER2-Negative Advanced Breast Cancer Physician's Weekly, 14 Sep 2022 Results from the second interim analysis of MONARCH 3 show that overall survival is numerically longer with abemaciclib plus a…